ABSTRACT
INTRODUCTION
Urinary incontinence (UI) is defi ned by the International Continence Society as any complaint of involuntary urine loss. 1 It is estimated that about 400 million persons worldwide are aff ected by UI 2 ; incontinence is strongly related to aging. 3 , 4 Although UI can be managed in various ways, the use of disposable absorbent incontinence products is common. Desirable characteristics of absorptive products are the ability to absorb urine without leaking (loss of containment) and the ability to reduce or eliminate odors. 5 , 6 Fear that such odors can
Most natural odors are caused by a mixture of volatile compounds. 8 , 9 Th ese compounds have a wide range of chemical structures present in variable concentrations, resulting in different odor characteristics. Th ere are 3 main approaches in odor research: (1) sensory methods for studying how odors of various objects are perceived by humans; (2) instrumental methods to analyze the contents of volatile compounds; and (3) a combination of sensory and instrumental methods to fi nd out which volatile compounds cause the odor of a particular object. Th e study presented in this article uses the combined approach.
Humans perceive odor when odorous compounds are emitted into the air and reach the nose. Th e composition of volatile compounds in the air (usually called the headspace) determines the character of the odors. One particular challenge in odor studies is to fi nd an object's "key odorants," the compounds that are the main contributors to the odor. Th e most common technique for identifying key odorants is gas chromatography-olfactometry (GC-O), which was originally developed to study fragrances and food aromas. In GC-O, human assessors sniff at the effl uent from the GC column.
refl ects the composition of the air that humans inhale when the odor of the object is perceived.
Development of these analytical techniques provides a basis for analysis of urinary volatiles present within an organism, cell, or tissue 11 and for diagnostic purposes. 12 Although the volatile compounds emitted from urine have been investigated in several studies, 13 research focusing on the odor potential of various urinary volatiles via the GC-O technique is sparse. Th e initial studies in this fi eld have used various extraction and distillation techniques to collect and enrich urinary volatiles. 14 , 15 Unfortunately this approach creates a somewhat-biased picture of what volatile compounds cause odor in urine.
Th e odor produced when an incontinence product is used is caused by more than the odorous compounds in urine alone. During use, an incontinence product comes into close contact with the urogenital area that contains varying levels of perspiration, cutaneous microfl ora, vaginal or urethral discharge, and possible fecal materials. Over time, volatile compounds can be generated via bacterial metabolism and/or a variety of chemical and enzymatic reactions. In a recent study of odorants released from used incontinence products, various volatile compounds were found. 16 Five (acetaldehyde, butanal, 3-methylbutanal, methanethiol, and hydrogen sulfi de) exceeded odor detection thresholds found in the literature and were therefore considered to contribute most to the odor. Th e aim of this study was to identify, using GC-O, the key odorants in used disposable, absorbent incontinence products. Th e study was part of a larger project in which the odors of used incontinence products were characterized by descriptive odor analysis.
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MATERIALS AND METHODS
Used incontinence products were collected from residents at geriatric nursing homes in the Gothenburg area of Sweden. Th e personnel were asked to collect products with noticeable odor from residents who frequently had odorous products. Th us, products with no odor or very faint odor were not sampled. No data on medications and medical diagnoses were collected.
Sample collection procedures were completed by the Swedish market research institute (ScandInfo, Goteborg, Sweden) in accordance with Swedish data privacy legislation (the Swedish Personal Data Act 1998) and the ICC/ESOMAR (International Code on Market and Social Research) in order to ensure the residents' privacy. Th is type of study, under Swedish Legislation, does not require review or approval by a Regional Ethical Review Board. Th e study did not involve any humans, only collection of used products. Th ere was no direct contact between ScandInfo's personnel and the residents. Th e nursing homes' Local Authority Senior Medicine Advisor and the nursing home managers have reviewed and approved the study.
Used incontinence products, one from each resident, were collected either at night or in the morning (wearing time 5-13 h). Each resident used her or his ordinary incontinence product (5 TENA [Stockholm Sweden], 2 Abri-San, 1 AbriWing [Aabenraa Denmark]). Th e products had no added odor control function, according to the package. Products containing fecal materials were excluded. Collected products were wrapped in plastic bags by the personnel, placed in insulated bags with ice packs, and transported to SCA's Gothenburg laboratory. No specifi c instructions were given to the personnel regarding sample handling.
Rectangular pieces (1 cm × 10 cm) were cut from the wet part of the incontinence products and placed in 500-mL glass bottles (Sovirel, France) with Tefl on-lined lids; 2 pieces in each bottle and a set with 10 to 12 bottles for each product. A bottle containing incontinence product pieces is hereafter referred to as a sample. A used incontinence product is hereafter referred to as a product.
Th e samples were immediately placed in insulated bags with ice packs and transported to SP Food and Bioscience's Gothenburg laboratory. Th ey were rapidly frozen with carbon dioxide ice and kept frozen ( − 40 ° C) for 3 to 4 months before analysis. Th e storage at this extra-low temperature was based on the outcomes of a prestudy in which no or only minor (from an odor point of view) noticeable changes were seen in the patterns of volatile, and potentially odorous, compounds in used incontinence products stored at − 40 ° C for 4 months.
Unused incontinence products, from the packages that the used products had come from, were also collected for use as reference (control) samples. Th ey were soaked with a 0.9% NaCl solution (400-600 mL, depending on absorption capacity of the product). After 30 minutes, they were cut and treated in the same way as the used products.
Th is study included products from 8 residents (7 females, 1 male; aged 64-90 years) selected from 14 products (designated S1-S14) that had previously been characterized by descriptive odor analysis. 17 Th e 8 products in this study were selected to cover as wide a variation in odor characteristics as possible, based on the results from the sensory characterization. 17 Th e same product designations (Sx) as used in the sensory study were used. Th e references to the used products were designated R-Sx. No used products were examined for microbial content.
Study Procedures
Th e headspace sampling of volatile compounds was done using a modifi cation of an established method. 18 Th e glass bottles used for frozen storage of the samples were also used as headspace sampling vessels. Th e frozen samples were thawed overnight in a refrigerator and then kept at room temperature for approximately 1 hour. Th e lids were then replaced by special headspace sampling adapters and the bottles were temperature-equilibrated in a water bath ( + 35 ° C) for 30 minutes. Th e inlet of the sampling vessel was connected to a gas supply system that delivered helium at a fi xed fl ow rate. Th e outlet was connected to a sampling cartridge fi lled with the adsorbent Tenax TA 60/80 (Grace Discovery Science, Deerfi eld, Illinois). Figure 1 shows a headspace sampling fl ask fi tted with a headspace sampling adapter. Th e volume of sampled gas was 1000 mL (gas fl ow rate: 20 mL/min; sampling time: 50 minutes).
Th e GC-O and GC-mass spectrometry (MS) analysis system consisted of a Trace 2000 GC and an Automass Solo MS (Th ermo Quest, Milan, Italy) combined with an ATD 400 thermal desorption unit (Perkin Elmer, Beaconsfi eld, UK). Th e GC was supplied with a 30 m × 0.32 mm DB-5 column (J&W, Agilent Technologies Folsom, CA). A Y-shaped nozzle, placed after the column, split the carrier gas fl ow between the fl ame ionization detector (FID) and MS, and the FID and the sniffi ng port used in the GC-O analysis. To reduce the amount of injected water, the Tenax cartridges were dried by minutes' initial and 10 minutes' fi nal holding times. Th e system's Xcalibur program, supplied with the NIST library for MS identifi cation, was used for storage and treatment of the data. In the GC-O confi guration, make-up gas (air, 50 mL/ min) was added to that part (about 80%) of the carrier gas that was passed through a heated (170 ° C) transfer line to the sniffing port where the carrier gas was mixed with humidifi ed air (100 mL/min). An outline of the system for GC-O analysis is shown in Figure 2 .
Two experienced assessors carried out the sniff analysis. As the chromatographic analysis proceeded, they recorded their odor observations on an FID chromatogram printed on an analog recorder. Odor intensities were assessed on a scale where 0 indicated "no perceived odor" to 5, which indicated "very strong odor." Th e assessors were instructed to, as far as possible, characterize the odors they perceived in their own words. Each GC-O analysis was divided into three 20-minute sniffi ng sessions. For each product, as well as for its reference, duplicate GC-O analyses were carried out. In the fi rst analysis, one assessor was sniffi ng during the fi rst and third sessions and the other assessor was sniffi ng during the second session. In the second analysis, the sniffi ng order was shifted between the assessors.
RESULTS
Outcomes of the GC-O and the GC-MS analyses are summarized in Table 1 . Th e odor intensity observations on each used product (Sx) are displayed in the column next to the observations for its corresponding reference product (R-Sx).
Based on the GC-O analysis, 28 volatile compounds in this study were defi ned as key odorants. Key odorant profi les varied between the studied products; the number of key odorants passing 400 mL of dry helium through them at room temperature. Volatile compounds were desorbed at 250 ° C for 5 minutes. Th e carrier gas was helium (3 mL/min) and the temperature program was 30 ° C to 220 ° C at 4 ° C/min, with 2 varied between 15 and 23 in each used product and between 7 and 11 in the reference products. Most key odorants could be identifi ed by MS and belonged to the following classes of compounds, in alphabetical order and giving the number of compounds in parentheses: aldehydes (6); amines (1); aromatics (3); isothiocyanates (1); heterocyclics (2); ketones (6); sulfur compounds (6); and terpenes (1) . Two compounds could not be identifi ed, as they were present at very low concentrations; nevertheless, the odors omitted from these were perceptible. Th is is a common fi nding in odor research and illustrates the sensitivity and usefulness of the nose as detector in the GC-O technique.
Of the 28 compounds defi ned as key odorants, 11 were judged to be strong or very strong in at least 1 used product. Th ese compounds were (from top to bottom in Table 1 ) 3-methylbutanal, nonanal, trimethylamine (TMA), cresol, guaiacol, 4,5-dimethylthiazole-S -oxide, diacetyl, dimethyl trisulfi de (DMTS), 5-methylthio-4-penten-2-ol, and 2 unidentifi ed compounds.
DISCUSSION
It has previously been shown that the odors of used incontinence products vary both in character and in intensity, 17 indicating a complex odor chemistry. As expected, the present study confi rms that used incontinence products emit large numbers of volatile compounds of diff erent classes. Th is is exemplifi ed in Figure 3 , which presents gas chromatograms obtained when analyzing headspace samples of volatile compounds emitted from 2 used incontinence products. Each peak was caused by at least one compound; this fi nding indicates that the products contained, and emitted, several hundred volatile compounds. In this study, only compounds of importance, according to the GC-O analysis, were identifi ed. Some compounds of potential importance may remain undetected in the analysis, as either they were not adsorbed by Tenax TA or do not chromatograph well on a DB-5 column. Examples of such compounds are ammonia and carboxylic acids.
Some of the key odorants were perceived with similar GC-O intensities in the used and reference incontinence products. Th is was the case for straight chain aldehydes and β -pinene, for example. Straight chain aldehydes are usually described as secondary lipid oxidation products and are commonly found in various wood-based materials. Also, terpenes are common contributors to the odors of wood-based materials. It is likely that these compounds primarily originated from the incontinence product itself, and not from the use of the product. All disposable absorbent incontinence products have an intrinsic odor from their constituent materials, which is more easily released when the product is wetted. Th e incontinence product materials contribute with a background odor that is nonspecifi c for diff erent patient groups. By carefully selecting the materials, the background odor may be reduced.
Th e odor intensity of 3-methylbutanal was medium strong to strong in most used incontinence products. Its odor was described as sweat, cheese, vomit, as well as green, and burnt. 3-Methylbutanal was perceived also in reference products, but only at low intensity. Its isomer, 2-methylbutanal, was also perceived, although generally at lower intensities compared to 3-methylbutanal. One possible source of 2-and 3-methylbutanal in used incontinence products is urine, as these compounds can sometimes be found in headspace samples of urine. 13 , 16 Another possible source is microbial metabolism.
During use, the products will come in close contact with the urogenital area containing microfl ora. Th e urine itself may also contain bacteria since the prevalence of bacteriuria is very high in institutionalized populations. 22 In this study, no urine samples from residents were collected; thus, no data on bacteriuria are available.
As previously mentioned, straight chain aldehydes seemed to originate mainly from the materials in the reference product. Still, nonanal was perceived as strong in 2 of the used products, but not in their corresponding reference. A consultation of the GC chromatograms (unpublished data), however, showed that nonanal was probably derived from the product itself, rather than from the use of the product.
A strong TMA odor, with a typically fi shy character, was perceived in one of the used incontinence products. Trimethylamine in the body generally has dietary origin and is mainly removed from the body, via the urine, as nonodorous trimethylamine-N -oxide. Studies have demonstrated that trimethylamine-N -oxide can be reduced to TMA by Escherichia coli 23 , 24 and that several uropathogens can produce TMA. 19 , 25 An underlying cause of TMA in urine can also be the rare metabolic condition trimethylaminuria, which leads to an excess of TMA in the body. 26 In some of the used incontinence products, the phenolic compounds cresol (unidentifi ed isomer) and guaiacol were perceived at medium strong to strong intensities. Normally, urine contains very little free cresol. 27 , 28 Th e para isomer of cresol is actually produced in the body, by bacterial degradation of tyrosine in the intestines, 29 , 30 but is mainly excreted in the urine in conjugated, nonodorous forms.
27 , 28 p -Cresol is known to have a horse stable-like, fecal odor, 31 and is considered to be one of the main contributors to the odor of pig farms. 32 Cresol in this study was associated with urine, urinal, stable, and tar. Guaiacol was described as having a smoked, earthy odor character. Guaiacol is likewise believed to be excreted in the urine, mainly in a conjugated form. 33 Th e conjugates can be hydrolyzed by enzymes found in bacteria and feces. 28 , 33-35 When these enzymes are present and active in used incontinence products, free odorous p -cresol and guaiacol may be released. It is also possible that p -cresol and guaiacol are generated by bacteria during the use of an incontinence product, as bacteria can produce both compounds in urine. Diacetyl was detected in all incontinence products, both used and unused, although the perceived odor intensities were generally higher in the used products. Th is compound has a characteristic buttery odor and is a common constituent of various natural systems, as well as food and beverages. Diacetyl can also sometimes be found in urine. 13 In addition, diacetyl is produced by several Lactobacillus species found in the female urogenital area 36 and also by some pathogens. 21 , 37 Dimethyl trisulfi de is considered to be of very high importance for the odor of used incontinence products, as its odor was perceived as strong or very strong in all tested, used products. No other compound was perceived with such high intensities, and as frequently, as DMTS. Th e GC-O assessors described DMTS as stinky, rubbery, fecal, garlicky, and nasty. Th is compound has been associated with livestock, and with fl avors and off -fl avors in food and beverages. 38 , 39 Apart from DMTS, various mono-and disulfi des were also perceived in the used incontinence products, although at lower intensities. Many of these sulfur compounds can be found in urine samples, 16 , 40 although mostly at low concentrations. 16 , 41 Sulfur compounds are also generated by a number of common uropathogens. 19 , 20 , 42 5-Methylthio-4-penten-2-ol and 4,5-dimethylthiazole-S-oxide were assessed as strong and medium strong in 2 of the used products. According to the GC-O assessors, the odor of 5-methylthio-4-penten-2-ol had a rubbery, garlicky character, and the odor of 4,5-dimethylthiazole-S-oxide was pungent, with an onion character. Little information is available about these compounds, but origins from food and medicines might be considered. 43 , 44 Th e odor character of one of the unidentifi ed compounds (unidentifi ed 1) was described as roasted, popcorn, nuts, burnt, milk. Th is compound was perceived as strong in 3 of the used products, with almost no odor contribution from the product itself.
Th e other unidentifi ed compound (unidentifi ed 2), with an odor character of mushroom and garlic, was likely derived largely from the product itself. Although the odor intensity of this compound was strong in one of the used products, the overall GC-O results indicate that the product itself emitted this compound, and that there was little or no contribution from the use of the product.
Of the odorants discussed earlier, 9 can be considered to be of particular importance. Th ese odorants were perceived as strong in 1 or more of the used incontinence products, and they originated fully or partially from the use of the product. Th ey were 3-methylbutanal, TMA, cresol, guaiacol, 4,5-dimethylthiazole-S -oxide, diacetyl, DMTS, 5-methylthio-4-penten-2-ol, and one of the unidentifi ed odorants (unidentifi ed 1).
For most of these key odorants of particular importance, there is clearly more than one possible origin of the odor. Many of these odorants can normally be found in the human body, as metabolites of human tissue or as metabolites of bacteria in the intestines. Th e odorants formed in the body can often also be detected in urine, although some of them are conjugated into nonodorous forms before excretion. Another possible cause of odor is bacteria present in the urine and the urogenital area, such as uropathogens and the normal urogenital microfl ora. Th e presence of bacteria in urine, that is, bacteriuria, is associated with UI, 45 , 46 and the prevalence of bacteriuria is particularly high among elderly people at nursing homes. 47 , 48 Many bacteria species often present in urine can potentially generate a number of odorants, 14 , 19 , 42 including most of the odorants identifi ed in this study to be of particular importance in the odor of used incontinence products. Besides being of urinary and bacterial origin, some odorants may also be the result of chemical and enzymatic reactions in the products during use. Odorants may also derive from body liquids other than urine, such as perspiration and vaginal or urethral discharges. Gender-specifi c diff erences in odorant content have not been investigated in this study as only 1 male resident was included, and further studies are needed for possible diff erences to be revealed.
Implications for Practice
Depending on the origin of the odorants, diff erent measures can be taken to reduce the odor in incontinence products. One is to target the microbial, enzymatic, or chemical processes that generate odorants in the product, for example, by including a bacterial or enzyme inhibitor. Another way is to remove already-existing odorants, such as those present in the voided urine, by using substances that, for example, adsorb or absorb them. Considering the high number of odorants identifi ed in the used incontinence products in this study, and the diff erent origins that they might have, a combination of odor inhibitors-targeting a variety of odorants with a variety of different origins-will have the highest probability of succeeding in removing odor.
Many people worldwide are suff ering from incontinence and have a constant fear of odor. In developing incontinence products, there is a need for better knowledge of the odorants of used incontinence products to minimize the discomfort of odor. Th e result of this article is a contribution to the eff ort of developing eff ective odor inhibition, as well as to the development of standardized laboratory methods for evaluation of the odor-inhibiting eff ect of incontinence products.
Limitations
A limited number of products were analyzed. Additional tests need to be performed to further identify key odorants of importance for the odor of used incontinence products. Complementary testing is also needed to identify compounds undetected in this study. Nevertheless, the knowledge of key odorants will contribute to development of disposable absorbent incontinence products with improved odor control.
CONCLUSIONS
Th e analyzed products contained large numbers of volatile compounds, 28 of which were defi ned as key odorants. Nine of the key odorants were considered to be of particular importance to the odor of the used incontinence products: 3-methylbutanal, TMA, cresol, guaiacol, 4,5-dimethylthiazole-S -oxide, diacetyl, DMTS, 5-methylthio-4-penten-2-ol, and 1 unidentifi ed compound.
